Search All UT System Experts

Prospective, randomized, double-blind, vehicle controlled, multicenter phase IIb clinical trial of the pore forming protein PRX302 for targeted treatment of symptomatic benign prostatic hyperplasia

Mostafa M. Elhilali, Peter Pommerville, Richard C. Yocum, Rosemina Merchant, Claus Roehrborn, Samuel R. Denmeade

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective, randomized, double-blind, vehicle controlled, multicenter phase IIb clinical trial of the pore forming protein PRX302 for targeted treatment of symptomatic benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences